Rothenberg’s innovative, FDA-approved technology will improve cardiac health through enhanced treatment and prevention.

Adults with chronic kidney disease (CKD) or type 2 diabetes develop cardiovascular diseases (CVD) at younger ages.

At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...

Recent research links prolonged sitting to an increased risk of heart disease, even with regular exercise, suggesting a need ...

As rates of obesity, as defined by body mass index (BMI), continue to climb in the United States, so have efforts to lose weight, including a new era of weight-loss drugs.

A new study reveals that excessive sitting may increase the risk of heart disease, even for those who exercise regularly.

A recent study published in the Journal of Translational Internal Medicine reveals insights into the broader impact of ...

New research indicates that people with cardiovascular-kidney-metabolic syndrome may have a higher risk of developing ...

More people living in rural areas of the United States are dying from heart attacks, strokes and other cardiovascular ...

For Esperion Therapeutics, 2024 has marked a pivotal transformation in its mission to combat cardiovascular disease. | ...

Women who drink 4 glasses of regular milk every day have a higher risk of heart disease, a new study has found. Fermented ...

Shared genetic factors may drive both osteoarthritis and cardiovascular disease, suggesting a common genetic basis that ...